Skip Navigation Links.
Collapse <span class="m110 colortj mt20 fontw700">Volume 12 (2024)</span>Volume 12 (2024)
Collapse <span class="m110 colortj mt20 fontw700">Volume 11 (2023)</span>Volume 11 (2023)
Collapse <span class="m110 colortj mt20 fontw700">Volume 10 (2022)</span>Volume 10 (2022)
Collapse <span class="m110 colortj mt20 fontw700">Volume 9 (2021)</span>Volume 9 (2021)
Collapse <span class="m110 colortj mt20 fontw700">Volume 8 (2020)</span>Volume 8 (2020)
Collapse <span class="m110 colortj mt20 fontw700">Volume 7 (2019)</span>Volume 7 (2019)
Collapse <span class="m110 colortj mt20 fontw700">Volume 6 (2018)</span>Volume 6 (2018)
Collapse <span class="m110 colortj mt20 fontw700">Volume 5 (2017)</span>Volume 5 (2017)
Collapse <span class="m110 colortj mt20 fontw700">Volume 4 (2016)</span>Volume 4 (2016)
Collapse <span class="m110 colortj mt20 fontw700">Volume 3 (2015)</span>Volume 3 (2015)
Collapse <span class="m110 colortj mt20 fontw700">Volume 2 (2014)</span>Volume 2 (2014)
Collapse <span class="m110 colortj mt20 fontw700">Volume 1 (2013)</span>Volume 1 (2013)
American Journal of Medical Case Reports. 2014, 2(6), 126-132
DOI: 10.12691/AJMCR-2-6-5
Original Research

Virulance Factors Enhancing Microbial Infection in Chronic Osteomylitis and Antibiotic Susceptability Pattern

Rana A. Mohsien1, Maysaa Ch. Al –Mohammedawi1, and Abdul Ghani I. Yahya1

1Biotechnology Department. /College of Science / AL-Nahrain University, Baghdad, Iraq

Pub. Date: July 15, 2014

Cite this paper

Rana A. Mohsien, Maysaa Ch. Al –Mohammedawi and Abdul Ghani I. Yahya. Virulance Factors Enhancing Microbial Infection in Chronic Osteomylitis and Antibiotic Susceptability Pattern. American Journal of Medical Case Reports. 2014; 2(6):126-132. doi: 10.12691/AJMCR-2-6-5

Abstract

Aims: To isolate and identify the causative agents for chronic osteomyelitis in patients and understanding their virulence factors for identification of targets for novel drugs and design of new vaccines. Study Design: samples of swab and bone tissues biopsy from chronic osteomylitis patients were collected in order to study the infectious agents by investigating their virulence factors. Place and Duration of study: Twenty five specimens of osteomyelitis were collected from chronic osteomyelitis patients at Surgical Specialist Hospital, Al-Yarmook Teaching Hospital and Baghdad Teaching Hospital during June 2010 to May 2011. Methodology: a form was designed to be filled by each patient, which included information about their age, sex, duration of infection, infection site. Specimens were collected using a sterile cotton swab and bunch of biopsy. The pus was taken before the surgery by swabbing an open infected area and from the deeper part of the infected bone, while, biopsies were taken from osteomyelitis patients during surgical management at the operation theater. Results: from fifty swab and twenty-five bone tissue biopsy samples, the results showed high prevalence of osteomyelitis in male patients with 84% (21), and 16% (4) in females. It was found that chronic osteomyelitis has a high prevalence among males with 84%, and the highest incidence was recorded at the age group of 30-39 years. Cultural, microscopic examination and bioc-hemical characterization of both swab and biopsy specimens, showed that 50% of the isolates were Staphylococcus aureus, 26% Enterobacter cloacae, 14% Pseudomonas aeruginosa, 6% Escherichia coli, and 4% Klebseilla sp. From the results of the antimicrobial susceptibility test using different (11) antibiotic discs against S. aureus, Enterobacter cloacae, Pseudomonas aeruginosa, E.coli, and Klebsiella sp. six isolates of S. aureus were selected and designated as (S1, S3, S4, S7) which showed multiple resistances to antibiotics. Conclusion: It was found that multiple resistances S. aureus isolates were able to produce haemolysin enzyme, capsules, slime layer, biofilm and hyaluronidase enzyme.

Keywords

Osteomyelitis, S. aureus, hyaluronidase, capsule, slime layer, biofilm

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  Sax, H. and Lew, D. Osteomyelitis. Curr. Infec. Dis. Rep. 1999; (1): 261-66.
 
[2]  Twaij, J.H.; AL-Najar, A.R. and AL-Hashemi, E. H. Clinical and bacteriological analysis of osteomyelitis. Iraqi J. Comm. Med. 2001; 14 (2): 201-205.
 
[3]  Paediator, J. (2005). Acute osteomyelitis and septic arthritis in children. Int. J. Antimicrobiol. Agent. 2005; (41): 59-62.
 
[4]  Chamber, H.F. The changing epidemiology of Staphylococcus aureus. Emerg. Infect. Dis. 2001; (7): 178-182.
 
[5]  Collee, J. G.; Miles, R. S. and Watt, B. Tests for the Identification of Bacteria. In: Mackie and MacCartney editors. Practical Medical Microbiology 14th ed. Churchill: Livingstone. 1996.
 
[6]  Cheesbrough, M. District Laboratory practice in tropical countries (Part II). Cambridge University, 2006; 19-110.
 
[7]  Atlas, R. N.; Brown, A. E. and Paks, L. G. Laboratory Manual of Experimental Microbiology. 1St ed. Mosby. USA. 1995.
 
[8]  Alfred, E. B. Benson's Microbiological Applications. Laboratory Manual in General Microbiology 9Th ed. Mc Graw Hill. USA. 2005.
 
[9]  Beveridge, A.; Tass, T.; Doduge, S. (2007). The demonstration of bacterial capsules and slime. J. Pathol. Bacteriol. 2007; 63 (4): 673-85.
 
[10]  Freeman, D. J.; Falkiner, F. R. and Keane, C.T. New method for detecting slime producing by coagulase negative Staphylococci. J. Clin. Pathol. 1989; (42): 872-874.
 
[11]  Mark, E.; Hart, G.; Morgan, J.; and Anna, J. Genotypic and Phenotypic Assessment of Hyaluronidase Among Type Strains of a Select Group of Staphylococcal Species. Int. J. Microbiol. 2009; 5 (5): 754-755.
 
[12]  Smith, R. F. and Willett, N. P. Rapid plate method for screening hyaluronidase and chondroitin sulfatase-producing microorganisms. Appl. Microbiol. 1968; 16 (9): 1434-1436.
 
[13]  King, S. J.; Allen, A. G.; Maskell, D. J.; Dowson, C. G. and what-more, A. M.-Distribution, Genetic diversity and variable expression of the gene encoding hyaluronate lyase with the Streptococcus suis. Pop. J. bacteriol. 2004; 186 (14): 4740-4747.
 
[14]  Humphreys, G. O., G. A. Wilshaw, and E. S. Anderson. 1975. A simple method for the preparation of large quantities of pure plasmid DNA. Biochim. Biophys. Acta 383: 457-463.
 
[15]  Trevors JT. Plasmid curing in bacteria. FEMS Microbiol Lett, 1986; 32: 149-157.
 
[16]  AL-Kateeb, A. N. Isolation of Aerobic and Anaerobic Bacteria From Patients With Osteomyelitis and Study Some of The Virulence Factors. Master in Microbiology. College of Science, AL-Mustansiriyah University. Baghdad, Iraq. 2005.
 
[17]  Calhoun J.H, Manring M.M. Adult osteomyelitis. Infect Dis. Clin. North Am. 2005; 19 (4): 765-86.
 
[18]  AL-Dieny, I. M. Bacteriological and Serological Study of Osteomyelitis Patients. Master in Biotechnology, College of Science, Baghdad University, Baghdad, Iraq. 2006.
 
[19]  Nam JR, Kim MS, Lee CH, Whang DH. Linezolid Treatment for Osteomyelitis due to Staphylococcus epidermidis with Reduced Vancomycin Susceptibility. J. Korean Neurosurg. Soc. 2008; 43 (6): 307-310.
 
[20]  Rebecca A. Brady L, Jeff G. Leid, Jason H. Calhou3, J. William Costerton & Mark E. Shirtliff. Osteomyelitis and the role of biofilms in chronic infection. FEMS Immunol Med Microbiol. 2008; (52) 13-22.
 
[21]  Sax, H. and Lew, D. Osteomyelitis. Curr. Infec. Dis. Rep. 1999; (1): 261-66.
 
[22]  Mohammad, R. P. and Saeed, N. Staphylococci. J. of Chinese Clin. Medicine. 2009; 4 (6). 67-71.
 
[23]  Zeidan, I. A. Bacteriological and Genetic Study on Different Clinical Samples of Staphylococcus aureus Resistant to Vancomycin. Master in Biotechnology. College of Science, Baghdad University, Baghdad, Iraq. 2005.
 
[24]  Korakaki, E. A.; Aliqizakis, A; Manoura, E.; Hatzidaki, E.; Saitakis, M.; Anatoliotaki, E.; Velivasakis, S.; Maraki, R. and Giannakopoulou, C. Methicillin-resistant Staphylococcus aureus osteomyelitis and septic arthritis in neonates: Diagnosis and management. Jap. J. Infect. Dis. 2007; (60): 29-31.
 
[25]  AL-Attar, N. S. M. (2007). Study on Pathogenecity of Enterobacter cloacae Isolated From Wound Infections in Some of Baghdad Hospitals. Master in Microbiology, College of Science, Baghdad University.
 
[26]  Hans, O. H. and Gunnar, L. Identification of Cephalosporin-Resistant Staphylococcus aureus With the Disc Diffusion Method. J. Antimicrob. Agents and Chemother. 2007; 1 (5): 422-426.
 
[27]  Suheyla, T. and Osman, K. Determination of Some Virulence Factors in Staphylococcus spp. Isolated From Various Clinical Samples. Turk. J. Med. Sci. 2006; (30): 127-132.
 
[28]  Ammendolia, M.G.; Dirosa, R.; Montanaro, R.; Arciola, C.R. and Baldassarri, L. Slime production and expression of the slime-associated antigen by Staphylococal clinical isolates. J. Clin. Microbiol. 1999; (37): 3235-3238.
 
[29]  Mathur, T.; Singhal, S.; Khan, S.; Upadhyay, D. J.; Fatma, T. and Rattan, A. Detection of Biofilm Formation Among The Clinic Isolates of Staphylococci. An Evaluation of Three Different Screening Methods. Indian J. of Med. Microbiol. 2006; 24 (1): 25-9.